Conditions: Asthma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 26
Healthy volunteers: no

Brief summary:
This is a randomized, multicenter, placebo-controlled, double-blind, parallel-group study evaluating Asmanex Twisthaler 220 mcg once daily (QD) in the evening (PM) compared with "Asmanex" Placebo QD PM for 12 weeks. Efficacy will be measured for the changes in forced expiratory volume in 1 second (FEV1) from baseline to the end of treatment period (Week 12 or end of the study).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Asmanex twisthaler intervention 2: Placebo for Asmanex twisthaler
Intervention descriptions: intervention 1: Asmanex Twisthaler 220 mcg provided once daily in the evening for 12 weeks intervention 2: Placebo for Asmanex Twisthaler 220 mcg, once daily in the evening for 12 weeks

Protocol document: